Trader consensus assigns very low implied probability to a U.S. nuclear explosive test, anchored by the 32-year testing moratorium since 1992 and ongoing adherence to Stockpile Stewardship Program protocols that certify warheads without full detonations. Key drivers include Russia's 2023 revocation of CTBT ratification and China's nuclear expansion, spurring congressional hearings on potential resumption—yet the Biden administration and National Nuclear Security Administration affirm no plans, emphasizing subcritical experiments like the May 2024 U1a shot at Nevada. Post-election leadership transitions and fiscal 2025 NNSA budget votes represent pivotal upcoming catalysts that could shift geopolitical risk assessments.
Résumé expérimental généré par IA à partir des données Polymarket · Mis à jourEssai nucléaire américain par… ?
Essai nucléaire américain par… ?
$544,679 Vol.
31 mars 2026
1%
$544,679 Vol.
31 mars 2026
1%
A nuclear test is defined as the intentional non-combat detonation of a device by the US that produces a nuclear chain reaction (fission or fusion), regardless of yield.
Accidents, radiological dispersal devices (bombs that spread radioactive material using conventional explosives such as "dirty bombs"), or actions by third parties will not count toward this market's resolution.
Tests not explicitly claimed by US may still qualify if a clear consensus of credible reporting attributes the nuclear detonation to US. For example, an unclaimed nuclear test analogous to the 1979 "Vela Incident" would count if credible reporting attributes it to the US.
The resolution source for this market will be a broad consensus of credible reporting.
Marché ouvert : Nov 5, 2025, 1:13 PM ET
Resolver
0x65070BE91...Resolver
0x65070BE91...Trader consensus assigns very low implied probability to a U.S. nuclear explosive test, anchored by the 32-year testing moratorium since 1992 and ongoing adherence to Stockpile Stewardship Program protocols that certify warheads without full detonations. Key drivers include Russia's 2023 revocation of CTBT ratification and China's nuclear expansion, spurring congressional hearings on potential resumption—yet the Biden administration and National Nuclear Security Administration affirm no plans, emphasizing subcritical experiments like the May 2024 U1a shot at Nevada. Post-election leadership transitions and fiscal 2025 NNSA budget votes represent pivotal upcoming catalysts that could shift geopolitical risk assessments.
Résumé expérimental généré par IA à partir des données Polymarket · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes